ArticleGland surgery2025
The value of C-TIRADS combined with multidimensional indicators in the diagnosis of papillary thyroid carcinoma.
Article in Gland surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Precise identification of papillary thyroid carcinoma (PTC) is crucial in clinical practice to prevent unnecessary treatment. This research aimed to combine metabolic function parameters and inflammatory markers to establish a multimodal diagnostic model using the Chinese Thyroid Imaging Reporting and Data System (C-TIRADS) for enhancing risk evaluation and improving clinical decision-making for PTC. Methods: A total of 314 patients with thyroid nodules were retrospectively enrolled, consisting of 193 cases of PTC and 121 cases of benign thyroid nodules (BTNs). These participants were randomly divided into a training set with 222 cases and a validation set with 92 cases at a ratio of 7:3. Univariate analysis and multivariate logistic regression were utilized to identify independent predictors for PTC diagnosis, leading to the creation of prediction models, including both baseline models and an integrated model. The discriminative ability of the integrated model was assessed using the area under the curve (AUC) of the receiver operating characteristic (ROC) curve. Subsequently, the diagnostic performance of the integrated model was compared with that of the baseline model. The calibration of the integrated model was evaluated using calibration curves in combination with the Hosmer-Lemeshow test. Results: Multivariate logistic regression identified C-TIRADS high-risk classification, body mass index (BMI), thyroid stimulating hormone (TSH), lymphocyte-to-monocyte ratio (LMR), age, and thyroglobulin (Tg) as independent predictors of PTC diagnosis. The integrated model exhibited significantly higher diagnostic efficiency compared to the baseline model in the training set (AUC: 0.903 Conclusions: The integrated model based on C-TIRADS classification combined with metabolic function parameters and inflammatory indicators has good efficacy in risk assessment of PTC, and can provide an objective quantitative tool for individual diagnostic evaluation and treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.